Skip to main content

H.R. 5189

Referred to Committee

Opioid Abuse Crisis Act of 2016

Introduced 5/11/2016•114th Congress•House

Latest Action

Referred to the Subcommittee on Military Personnel.

6/7/2016 • House

Summary

Opioid Abuse Crisis Act of 2016

This bill appropriates funding for activities in this bill.

This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to provide support for activities related to opioid abuse, including treatment services. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)

This bill amends the Controlled Substances Act, including to permit a pharmacist to partially fill a prescription for certain drugs.

This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to refer new drug applications for opioids without abuse deterrent properties to an advisory committee.

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to permit the Department of Justice (DOJ) to support opioid abuse services and programs for veterans.

Opioid Program Evaluation Act or the OPEN Act

DOJ and HHS must have a nonfederal entity evaluate the grants established by this bill.

Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act

The Department of Veterans Affairs (VA) and the Department of Defense (DOD) must update the VA/DOD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain.

The VA must carry out activities related to opioid abuse, including expanding the opioid safety initiative to include all VA medical facilities.

Improving Safe Care for the Prevention of Infant Abuse and Neglect Act

The national clearinghouse for child abuse information must provide information on plans of safe care for infants born affected by substance abuse.

This bill amends the Social Security Act, including to permit prescription drug plan sponsors to establish programs for beneficiaries at-risk for prescription drug abuse.

Introduced in House • 5/11/2016

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Accounting and auditingAdvisory bodiesAfghanistanAlternative treatmentsAsiaAthletesChild healthChild safety and welfareCivil actions and liabilityCommunity life and organizationConflicts and warsCongressional oversightDepartment of Veterans AffairsDisability assistanceDomestic violence and child abuseDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco useEmergency medical services and trauma care

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (1)

Sponsor

R[
Rep. Kuster, Ann M. [D-NH-2]

Democrat • NH-2

Sponsored 5/11/2016

No cosponsors yet

Cosponsors may be added as the bill moves through Congress

Bill Journey

Originated in the House

Introduced

May 11, 2016

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Veterans' Affairs, Education and the Workforce, Ways and Means, Armed Services, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in House5/11/2016

Related Bills (23)

S. 2872

NAS Healthy Babies Act

RelatedView bill →

H.R. 4586

Lali's Law

RelatedView bill →

H.R. 1818

Veteran Emergency Medical Technician Support Act of 2016

RelatedView bill →

H.R. 4599

Reducing Unused Medications Act of 2016

RelatedView bill →

H.R. 4969

John Thomas Decker Act of 2016

RelatedView bill →

H.R. 4976

Opioid Review Modernization Act of 2016

RelatedView bill →

H.R. 4983

To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.

RelatedView bill →

H.R. 5048

Good Samaritan Assessment Act of 2016

RelatedView bill →

H.R. 5052

OPEN Act

RelatedView bill →

H.R. 271

COVER Act

RelatedView bill →

H.R. 2298

Medicare Patient Safety and Drug Abuse Prevention Act

RelatedView bill →

H.R. 3680

Co-Prescribing to Reduce Overdoses Act of 2016

RelatedView bill →

H.R. 3691

Improving Treatment for Pregnant and Postpartum Women Act of 2016

RelatedView bill →

H.R. 4063

Jason Simcakoski PROMISE Act

RelatedView bill →

H.R. 4843

Infant Plan of Safe Care Improvement Act

RelatedView bill →

H.R. 4981

Opioid Use Disorder Treatment Expansion and Modernization Act

RelatedView bill →

H.R. 4982

Examining Opioid Treatment Infrastructure Act of 2016

RelatedView bill →

H.R. 5046

Comprehensive Opioid Abuse Reduction Act of 2016

RelatedView bill →

S. 3015

John Thomas Decker Act of 2016

RelatedView bill →

H.R. 4978

NAS Healthy Babies Act

RelatedView bill →

H.R. 5145

To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.

RelatedView bill →

H.R. 5216

Opioid and Heroin Abuse Crisis Investment Act of 2016

RelatedView bill →

S. 3223

Expanded Access to Treatment and Recovery Act

RelatedView bill →

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors0